Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Mexico Polyphenol Market

ID: MRFR/CnM/45581-HCR
111 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

Mexico Polyphenol Market Research Report: By Source (Fruits, Vegetables, Whole Grains, Beverages), By Type (Flavonoids, Phenolic Acids, Stilbenes, Lignans), and By Application (Food & Beverage, Dietary Supplement, Cosmetics, Pharmaceuticals) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Mexico Polyphenol Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Application (USD Million)
  49.     4.1.1 Food and Beverages
  50.     4.1.2 Pharmaceuticals
  51.     4.1.3 Cosmetics
  52.     4.1.4 Nutraceuticals
  53.   4.2 Chemicals and Materials, BY Source (USD Million)
  54.     4.2.1 Fruits
  55.     4.2.2 Vegetables
  56.     4.2.3 Herbs
  57.     4.2.4 Tea
  58.   4.3 Chemicals and Materials, BY Form (USD Million)
  59.     4.3.1 Powder
  60.     4.3.2 Liquid
  61.     4.3.3 Capsules
  62.     4.3.4 Tablets
  63.   4.4 Chemicals and Materials, BY End Use (USD Million)
  64.     4.4.1 Health Supplements
  65.     4.4.2 Functional Foods
  66.     4.4.3 Personal Care Products
  67. 5 SECTION V: COMPETITIVE ANALYSIS
  68.   5.1 Competitive Landscape
  69.     5.1.1 Overview
  70.     5.1.2 Competitive Analysis
  71.     5.1.3 Market share Analysis
  72.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  73.     5.1.5 Competitive Benchmarking
  74.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  75.     5.1.7 Key developments and growth strategies
  76.       5.1.7.1 New Product Launch/Service Deployment
  77.       5.1.7.2 Merger & Acquisitions
  78.       5.1.7.3 Joint Ventures
  79.     5.1.8 Major Players Financial Matrix
  80.       5.1.8.1 Sales and Operating Income
  81.       5.1.8.2 Major Players R&D Expenditure. 2023
  82.   5.2 Company Profiles
  83.     5.2.1 Indena S.p.A. (IT)
  84.       5.2.1.1 Financial Overview
  85.       5.2.1.2 Products Offered
  86.       5.2.1.3 Key Developments
  87.       5.2.1.4 SWOT Analysis
  88.       5.2.1.5 Key Strategies
  89.     5.2.2 Kemin Industries, Inc. (US)
  90.       5.2.2.1 Financial Overview
  91.       5.2.2.2 Products Offered
  92.       5.2.2.3 Key Developments
  93.       5.2.2.4 SWOT Analysis
  94.       5.2.2.5 Key Strategies
  95.     5.2.3 Polyphenols Canada Inc. (CA)
  96.       5.2.3.1 Financial Overview
  97.       5.2.3.2 Products Offered
  98.       5.2.3.3 Key Developments
  99.       5.2.3.4 SWOT Analysis
  100.       5.2.3.5 Key Strategies
  101.     5.2.4 Nutraceutical Corporation (US)
  102.       5.2.4.1 Financial Overview
  103.       5.2.4.2 Products Offered
  104.       5.2.4.3 Key Developments
  105.       5.2.4.4 SWOT Analysis
  106.       5.2.4.5 Key Strategies
  107.     5.2.5 Ginkgo BioWorks, Inc. (US)
  108.       5.2.5.1 Financial Overview
  109.       5.2.5.2 Products Offered
  110.       5.2.5.3 Key Developments
  111.       5.2.5.4 SWOT Analysis
  112.       5.2.5.5 Key Strategies
  113.     5.2.6 Naturex S.A. (FR)
  114.       5.2.6.1 Financial Overview
  115.       5.2.6.2 Products Offered
  116.       5.2.6.3 Key Developments
  117.       5.2.6.4 SWOT Analysis
  118.       5.2.6.5 Key Strategies
  119.     5.2.7 BASF SE (DE)
  120.       5.2.7.1 Financial Overview
  121.       5.2.7.2 Products Offered
  122.       5.2.7.3 Key Developments
  123.       5.2.7.4 SWOT Analysis
  124.       5.2.7.5 Key Strategies
  125.     5.2.8 DSM Nutritional Products (CH)
  126.       5.2.8.1 Financial Overview
  127.       5.2.8.2 Products Offered
  128.       5.2.8.3 Key Developments
  129.       5.2.8.4 SWOT Analysis
  130.       5.2.8.5 Key Strategies
  131.   5.3 Appendix
  132.     5.3.1 References
  133.     5.3.2 Related Reports
  134. 6 LIST OF FIGURES
  135.   6.1 MARKET SYNOPSIS
  136.   6.2 MEXICO MARKET ANALYSIS BY APPLICATION
  137.   6.3 MEXICO MARKET ANALYSIS BY SOURCE
  138.   6.4 MEXICO MARKET ANALYSIS BY FORM
  139.   6.5 MEXICO MARKET ANALYSIS BY END USE
  140.   6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  141.   6.7 RESEARCH PROCESS OF MRFR
  142.   6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  143.   6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  144.   6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  145.   6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  146.   6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  147.   6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
  148.   6.14 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
  149.   6.15 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Million)
  150.   6.16 CHEMICALS AND MATERIALS, BY FORM, 2024 (% SHARE)
  151.   6.17 CHEMICALS AND MATERIALS, BY FORM, 2024 TO 2035 (USD Million)
  152.   6.18 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
  153.   6.19 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
  154.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  155. 7 LIST OF TABLES
  156.   7.1 LIST OF ASSUMPTIONS
  157.     7.1.1
  158.   7.2 Mexico MARKET SIZE ESTIMATES; FORECAST
  159.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  160.     7.2.2 BY SOURCE, 2026-2035 (USD Million)
  161.     7.2.3 BY FORM, 2026-2035 (USD Million)
  162.     7.2.4 BY END USE, 2026-2035 (USD Million)
  163.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  164.     7.3.1
  165.   7.4 ACQUISITION/PARTNERSHIP
  166.     7.4.1

Mexico Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2022-2035)

  • Food and Beverages
  • Pharmaceuticals
  • Cosmetics
  • Nutraceuticals

Chemicals and Materials By Source (USD Million, 2022-2035)

  • Fruits
  • Vegetables
  • Herbs
  • Tea

Chemicals and Materials By Form (USD Million, 2022-2035)

  • Powder
  • Liquid
  • Capsules
  • Tablets

Chemicals and Materials By End Use (USD Million, 2022-2035)

  • Health Supplements
  • Functional Foods
  • Personal Care Products

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions